Three decades of clinical trials with beta-blockers: The contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias

Journal of the American College of Cardiology

Volumn 45, Issue 4, 2005, Pages 531-532

  Pratt, Craig M ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; ENDOTHELIN; PLACEBO; POTASSIUM CHANNEL HERG;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANTIARRHYTHMIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARDIOPULMONARY HEMODYNAMICS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; NOTE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 13544274230     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.034     Document Type: Editorial

References (16)

1. Norwegian Multicenter Study Group Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
2. Beta-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction I. Mortality results JAMA 247 1982 1707 1714
3. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
4. M.A. Pfeffer, E. Braunwald, L.A. Moye., on behalf of the SAVE Investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 327 1992 669 677
5. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
6. B. Pitt, F. Zannad, W.J. Remme., for the Randomized Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
7. M. Packer, M.R. Bristow, J.N. Cohn., for the U.S Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 1996 1349 1355
8. M. Packer, M.B. Fowler, E.B. Roecker., Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study Circulation 106 2002 2194 2199
9. CAPRICORN Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
10. McMurray J, Køber L, Robertson M, et al. Antiarrhythmic effect of carvediolol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 2005;45:525-30.
11. C.A. Karle, V.A.W. Kreye, D. Thomas Antiarrhythmic drug carvedilol inhibits HERG potassium channels Cardiovasc Res 49 2001 361 370
12. A. Hallstrom, C.M. Pratt, H.L. Greene The interrelationships between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial (CAST) J Am Coll Cardiol 25 1995 1250 1257
13. J.T. Bigger, J.L. Fleiss, R. Kleiger, J.P. Miller, L.M. Rolnitzky the Multicenter Post-Infarction Research Group The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction Circulation 69 1984 250 258
14. L. Kober, P.E. Bloch-Thomsen., for the Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial Lancet 356 2000 2052 2058
15. C. Torp-Pedersen, M. Moller, P.E. Bloch-Thomsen., for the Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group Dofetilide in patients with congestive heart failure and left ventricular dysfunction N Engl J Med 341 1999 857 865
16. C.M. Pratt, S.N. Singh, H.R. Al-Khalidi., for the ALIVE Investigators The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial J Am Coll Cardiol 43 2004 1211 1216